retatrutide glp-1 gip glucagon agonist Retatrutide, a GIP, and receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Pharmacotherapies under investigation based on

Tuy nhin, theo C&EN, ngun tin khng l ny s bt u thu hp khi cc bng sng ch ca semaglutide ht hn ti nhiu th trng ln, bao gm n , Trung Quc v Brazil t thng 3/2026

Using 1:1 matching, we compared those who started a GLP-1RA against closely matched patients who didn't, across two groups: one on 5-ASA or no IBD therapy (2,028 pairs), and one on immunomodulators or advanced therapies (346 pairs)

Dave is the creator of Bulletproof Coffee, host of the #1 health podcast Bulletproof Radio, and author of the New York Times bestselling book, The Bulletproof Diet

Consider tracking your: Cycle dates: Record when your period starts and ends

One of the key benefits of Ozempic is its ability to stimulate significant weight loss, which can help lower the risk of a variety of obesity-related diseases